ARL14 as a Prognostic Biomarker in Non-Small Cell Lung Cancer
Binbin Zhang,Aiqun Xu,Dong Wu,Wanli Xia,Pulin Li,Enze Wang,Rui Han,Peng Sun,Sijing Zhou,Ran Wang
DOI: https://doi.org/10.2147/JIR.S340119
IF: 4.5
2021-12-07
Journal of Inflammation Research
Abstract:Binbin Zhang, 1, &ast Aiqun Xu, 2, &ast Dong Wu, 1, &ast Wanli Xia, 3, &ast Pulin Li, 1 Enze Wang, 1 Rui Han, 1 Peng Sun, 1 Sijing Zhou, 4, 5 Ran Wang 1 1 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People's Republic of China; 2 Department of General Medicine, Hefei Second People's Hospital, Hefei, Anhui Province, People's Republic of China; 3 Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People's Republic of China; 4 Hefei Third Clinical College of Anhui Medical University, Hefei, Anhui Province, People's Republic of China; 5 Hefei Prevention and Treatment Center for Occupational Diseases, Hefei, Anhui Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Sijing Zhou Hefei Prevention and Treatment Center for Occupational Diseases, Hefei, 230022, People's Republic of China Tel/Fax +86 551-63672040 Email Ran Wang Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China , Tel/Fax +86-551-6292-2914 Email Purpose: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. The mechanisms underlying NSCLC initiation and progression require further investigation. The purpose of this study was to investigate the role of ADP ribosylation factor-like GTPase 14 (ARL14) related to the progression of NSCLC. Patients and Methods: We analyzed the correlation between clinical characteristics and ARL14 expression using data from The Cancer Genome Atlas (TCGA). Kaplan–Meier analysis was conducted to evaluate the prognostic value of ARL14 in NSCLC. Functions of ARL14 were identified by enrichment analysis. The relationship between ARL14 expression and immune cell infiltration was also studied. Furthermore, ARL14 expression was examined using immunohistochemistry, and its clinical significance was analyzed in 120 patients with NSCLC. Results: Our study revealed that the expression level of ARL14 in patients with NSCLC was higher than that in normal tissues. Using TCGA data, higher ARL14 expression in lung adenocarcinoma was associated with residual tumor (P = 0.017), while it was associated with age (P = 0.003) and N stage (P = 0.009) in lung squamous cell carcinoma. Similar results were obtained from 120 patients with NSCLC. High ARL14 expression was associated with poor overall survival and progression-free survival in NSCLC. Multivariate analysis revealed that ARL14 was an independent risk factor for patients with NSCLC. Functional enrichment analysis indicated that ARL14 was related to the occurrence and development of tumors. Conclusion: Increased ARL14 expression was considerably correlated with poor survival in NSCLC, and it might be a promising prognostic biomarker for NSCLC. Keywords: ADP ribosylation factor-like GTPase 14, non-small cell lung cancer, prognosis, immunohistochemistry, bioinformatics Graphical Lung cancer is the most commonly diagnosed cancer worldwide and the leading cause of cancer-related deaths (18.4% of the total cancer deaths). 1 Non-small cell lung cancer (NSCLC) accounts for 83% of all lung cancer cases with a 5-year survival rate of 23% after diagnosis. 2 Lung adenocarcinomas (LUADs) and squamous cell cancers (LUSCs) are the most significant NSCLC subgroups. 3 Despite the development of medical technology such as increasing immunotherapy, the prognosis for NSCLC remains poor, which highlights the need to identify oncogenic and tumor-suppressive genes related to patient prognosis as molecular biomarkers. 4–7 ADP ribosylation factor-like GTPase 14 (ARL14), also known as ARF7 and FLJ22595, is a protein-coding gene that participates in GTP binding and signal transduction. 8,9 It is a member of the ADP ribosylation factor (ARF) family of GTP-binding proteins of the Ras superfamily. The primary function of ARF family proteins is to mediate the recruitment of cytosolic effectors to specific membrane compartments. 10–12 As central control elements, GTPases participate in signal transduction pathways, which touch almost every aspect of cell biology. 13 Recently, some studies have shown that ARL14 plays a key role in a wide range of biological processes such as intracellular protein transport and vesicle-mediated transport. 14 The met -Abstract Truncated-
immunology